TY - JOUR
T1 - Management and referral patterns for new-onset chronic cough in primary care patients
AU - Ringus, Daina L.
AU - Li, Sylvia H.
AU - Vu, Thanh Huyen T.
AU - Guo, Amina
AU - Yuksel, Selcen
AU - Arch, Rebecca S.
AU - Patel, Amee K.
AU - Patel, Gayatri B.
AU - Peters, Anju T.
N1 - Funding Information:
From the 1Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, and 2Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois AT Peters has received grants and research support from Merck. GB Patel has received grants from Merck & Co, and Merck, Sharp and Dohme. T-H T Vu has received grants and honorariums from Merck. The remaining authors have no conflicts to declare pertaining to this article. No external funding sources reported Address correspondence to Anju T. Peters, M.D., Division of Allergy and Immunology, Department of Medicine, Feinberg School of Medicine, Northwestern University, 211 E. Ontario, Suite 1000, Chicago, IL 60611 E-mail address: anjupeters@northwestern.edu Copyright © 2022, OceanSide Publications, Inc., U.S.A.
Publisher Copyright:
Copyright © 2022, OceanSide Publications, Inc., U.S.A.
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Background: The diagnosis and management of chronic cough in primary care is challenging despite it being one of the most common chronic conditions. Objective: Clinical characterization of patients with new-onset chronic cough in the primary care setting. Methods: This was a retrospective study of adult patients (ages ≥ 18 years) with at least three visits with primary care providers (PCP) for new-onset cough, with at least 8 weeks between the first and third visits, within a tertiary-care center and affiliated clinics between January 1, 2010, and January 1, 2019 (N = 174). We calculated the frequency of primary care visits, diagnostic testing, specialist referrals, and prescribed medications up to 18 months after the third visit with a PCP for cough. Results: Of 174 patients who met the criteria of new-onset chronic cough, >50% had four or more primary care visits related to cough. Despite that, 91 (52.3%) did not receive a referral to a specialist, and 41 (23.5%) did not receive an order for a chest radiograph during the evaluation of the chronic cough. Antibiotics and systemic corticosteroids were prescribed to 106 (61%) and 63 (36%) of the patients, respectively, and 20% were prescribed opiates. No patients were prescribed central-neuromodulating agents, and angiotensin-converting enzyme inhibitors were discontinued in 48% of the patients who were taking them (12/25). Conclusion: We found considerable heterogeneity and discrepancies with clinical guideline recommendations in patients who presented with new chronic cough. There is a substantial unmet need to study chronic cough in the primary care setting to inform important stakeholders.
AB - Background: The diagnosis and management of chronic cough in primary care is challenging despite it being one of the most common chronic conditions. Objective: Clinical characterization of patients with new-onset chronic cough in the primary care setting. Methods: This was a retrospective study of adult patients (ages ≥ 18 years) with at least three visits with primary care providers (PCP) for new-onset cough, with at least 8 weeks between the first and third visits, within a tertiary-care center and affiliated clinics between January 1, 2010, and January 1, 2019 (N = 174). We calculated the frequency of primary care visits, diagnostic testing, specialist referrals, and prescribed medications up to 18 months after the third visit with a PCP for cough. Results: Of 174 patients who met the criteria of new-onset chronic cough, >50% had four or more primary care visits related to cough. Despite that, 91 (52.3%) did not receive a referral to a specialist, and 41 (23.5%) did not receive an order for a chest radiograph during the evaluation of the chronic cough. Antibiotics and systemic corticosteroids were prescribed to 106 (61%) and 63 (36%) of the patients, respectively, and 20% were prescribed opiates. No patients were prescribed central-neuromodulating agents, and angiotensin-converting enzyme inhibitors were discontinued in 48% of the patients who were taking them (12/25). Conclusion: We found considerable heterogeneity and discrepancies with clinical guideline recommendations in patients who presented with new chronic cough. There is a substantial unmet need to study chronic cough in the primary care setting to inform important stakeholders.
UR - http://www.scopus.com/inward/record.url?scp=85141359219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141359219&partnerID=8YFLogxK
U2 - 10.2500/aap.2022.43.220071
DO - 10.2500/aap.2022.43.220071
M3 - Article
C2 - 36335417
AN - SCOPUS:85141359219
VL - 43
SP - E72-E79
JO - New England and regional allergy proceedings
JF - New England and regional allergy proceedings
SN - 1088-5412
IS - 6
ER -